CCRN - Cross Country Healthcare, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$14.00
DETAILS
HIGH:
$14.00
LOW:
$14.00
MEDIAN:
$14.00
CONSENSUS:
$14.00
UPSIDE:
5.66%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 18.7% |
| EBIT Margin | -7.7% |
| EBITDA Margin | -6.1% |
| Operating Margin | -0.3% |
| Pretax Margin | -7.9% |
| Cont. Ops Margin | -9.0% |
| Net Margin | -9.0% |
| Bottom Line Margin | -9.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.78 |
| Quick Ratio | 3.78 |
| Solvency Ratio | -0.619 |
| Cash Ratio | 1.40 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | -0.00 |
| Forward PEG | -0.00 |
| Price/Book | 0.81 |
| Price/Sales | 0.25 |
| Price/FCF | 6.55 |
| Price/Op Cash Flow | 5.44 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0052 |
| Debt/Equity | 0.0072 |
| Debt/Capital | 0.0071 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.39 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 4.90 |
| Operating Cash Flow Ratio | 0.621 |
| Operating Cash Flow/Sales | 4.6% |
| Free Cash Flow/Operating Cash Flow | 83.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -34.22 |
| Interest Coverage | -1.5623 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | 20.82 |
| Capital Expenditure Coverage | 5.91 |
| Dividend + Capital Expenditure Coverage | 5.91 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 32.53 |
| EPS | -2.927 |
| Debt/Share | 0.1399 |
| Cash/Share | 3.36 |
| Book Value/Share | 9.96 |
| Tangible BV/Share | 7.14 |
| Equity/Share | 9.96 |
| Operating Cash Flow/Share | 1.489 |
| Capital Expenditure/Share | 0.252 |
| FCF/Share | 1.237 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.136 |
| Earnings Before Tax/EBIT | 24.122 |
| Price/Fair Value | 0.81 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | -13.6% |
| Enterprise Value Multiple | -2.42 |